What are the indications for hemoperfusion?

Indications for Hemoperfusion

Hemoperfusion is primarily indicated for acute poisoning and drug overdose with specific toxins that are highly protein-bound, have small volumes of distribution, and are effectively adsorbed by hemoperfusion cartridges. 1, 2

Primary Clinical Indications

Acute Poisoning (Most Established Use)

Hemoperfusion should be considered when ALL of the following criteria are met 3:

1. The poison is effectively adsorbed by hemoperfusion cartridges from human blood
2. Small distribution volume - the toxin remains primarily in the bloodstream rather than tissue
3. Relatively long spontaneous half-life - natural elimination is slow enough that extracorporeal removal provides meaningful benefit
4. Clinical evidence demonstrates that hemoperfusion can reduce total body toxin load to a clinically relevant extent

Specific Toxins with Evidence

• Long-acting anticoagulant rodenticides (brodifacoum, bromadiolone): Hemoperfusion effectively reduces serum concentrations and may shorten vitamin K1 therapy duration, particularly for brodifacoum poisoning 4

• Highly protein-bound drugs and toxins where hemodialysis alone is insufficient 2

Emerging Critical Care Applications

The HA330/HA380 hemoperfusion cartridge shows promise in intensive care settings for 5:

• Sepsis and septic shock - removes inflammatory mediators (IL-6, IL-10, TNF-α)
• Severe COVID-19 with hyperinflammation
• Post-cardiac surgery inflammatory response
• Acute pancreatitis with systemic inflammation
• Blunt trauma with systemic inflammatory response
• Liver failure (toxin removal)

Important caveat: These critical care applications are still investigational with small-scale studies showing potential benefit but lacking large randomized controlled trials 5.

Key Technical Considerations

When Hemoperfusion is NOT Indicated

• Large volume of distribution - if the toxin is extensively distributed in tissues, removing it from blood provides minimal benefit 3
• Rapid spontaneous elimination - if the body clears the toxin quickly on its own
• Poor adsorption characteristics - the specific toxin is not effectively removed by available cartridges

Critical Warning About Drug Interactions

The HA330/HA380 cartridge adversely adsorbs antibiotics - appropriate antibiotic dosing adjustment and plasma drug level monitoring is mandatory when using hemoperfusion in infected patients 5.

Decision Algorithm

1. Identify the specific toxin - hemoperfusion effectiveness is toxin-specific
2. Assess pharmacokinetics:
   • Volume of distribution (prefer <1 L/kg)
   • Protein binding (prefer >80%)
   • Endogenous clearance rate
3. Evaluate clinical severity - life-threatening poisoning with inadequate response to supportive care
4. Confirm adsorption capacity - verify the specific toxin is removed by available cartridges
5. Consider timing - earlier intervention is more effective before tissue distribution occurs

Hemoperfusion remains underutilized in Western countries but continues as a valuable tool in developing nations, particularly for acute poisoning cases 2. The technique requires selective application based on toxin characteristics rather than broad, non-specific use 6.